ATE240717T1 - Wässrige formulierung zur nasalen verabreichung - Google Patents

Wässrige formulierung zur nasalen verabreichung

Info

Publication number
ATE240717T1
ATE240717T1 AT00951876T AT00951876T ATE240717T1 AT E240717 T1 ATE240717 T1 AT E240717T1 AT 00951876 T AT00951876 T AT 00951876T AT 00951876 T AT00951876 T AT 00951876T AT E240717 T1 ATE240717 T1 AT E240717T1
Authority
AT
Austria
Prior art keywords
nasal administration
aqueous formulation
aqueous
anhydrate
formulation
Prior art date
Application number
AT00951876T
Other languages
English (en)
Inventor
Rika Akutsu
Kenji Hosoya
Koho Kawamura
Yasuhiro Mishima
Tomohisa Onozaki
Nobuya Sugibayashi
Original Assignee
Glaxosmithkline Kabushiki Kais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Kabushiki Kais filed Critical Glaxosmithkline Kabushiki Kais
Application granted granted Critical
Publication of ATE240717T1 publication Critical patent/ATE240717T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00951876T 1999-08-07 2000-08-03 Wässrige formulierung zur nasalen verabreichung ATE240717T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9918559.7A GB9918559D0 (en) 1999-08-07 1999-08-07 Novel pharmaceutical formulation
PCT/JP2000/005200 WO2001010409A1 (en) 1999-08-07 2000-08-03 Aqueous nasal formulation

Publications (1)

Publication Number Publication Date
ATE240717T1 true ATE240717T1 (de) 2003-06-15

Family

ID=10858698

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00951876T ATE240717T1 (de) 1999-08-07 2000-08-03 Wässrige formulierung zur nasalen verabreichung

Country Status (9)

Country Link
US (1) US6780398B1 (de)
EP (1) EP1200066B1 (de)
JP (1) JP2003506396A (de)
AT (1) ATE240717T1 (de)
AU (1) AU6471500A (de)
DE (1) DE60002885T2 (de)
ES (1) ES2199845T3 (de)
GB (1) GB9918559D0 (de)
WO (1) WO2001010409A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US20050147584A1 (en) * 2004-01-05 2005-07-07 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
CA2550811C (en) * 2003-12-24 2012-05-01 Jane Hirsh Temperature-stable formulations, and methods of development thereof
EP1645266A1 (de) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Wässrige Suspension für Nasentropfen
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
CN100369608C (zh) * 2006-03-15 2008-02-20 修涞贵 一种治疗过敏性鼻炎的混悬液型喷雾剂及制备方法
JP5258315B2 (ja) * 2007-05-25 2013-08-07 ロート製薬株式会社 フルニソリド含有粘膜適用組成物
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
EP2453872B1 (de) * 2009-07-17 2013-08-21 Alcon Research, Ltd. Olopatadin-nasenspraybehandlung für kinder
EP2736491B1 (de) * 2011-01-04 2017-04-05 Bausch & Lomb Incorporated Bepotastin-zusammensetzung
EP2704687B1 (de) * 2011-05-04 2015-07-08 Chiesi Farmaceutici S.p.A. Topische formulierung mit einem corticosteroid als wirkstoff
BR112014004418A8 (pt) * 2011-08-25 2018-01-23 Evoke Pharma Inc método de tratamento de sintomas associados à gastroparesia feminina
WO2013049538A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. Allergen nasal compositions
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
EP3554489A4 (de) 2016-12-15 2020-06-17 Evoke Pharma, Inc. Behandlung von mässiger bis schwerer gastroparese
AU2022323269A1 (en) * 2021-08-04 2024-02-29 Indivior Inc. Compositions and methods for the treatment of opioid overdose
WO2025017382A1 (en) * 2023-07-15 2025-01-23 Aodh Lifesciences Private Limited Azithromycin nasal spray formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
EP0780127A1 (de) * 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin
BR9709650A (pt) * 1996-06-04 1999-08-10 Procter & Gamble Aerosol nasal contendo um esteróide intransal e um anti-histamínico
GB9806937D0 (en) * 1998-03-31 1998-05-27 Procter & Gamble A spray device

Also Published As

Publication number Publication date
AU6471500A (en) 2001-03-05
DE60002885T2 (de) 2004-03-11
DE60002885D1 (de) 2003-06-26
GB9918559D0 (en) 1999-10-06
JP2003506396A (ja) 2003-02-18
WO2001010409A1 (en) 2001-02-15
US6780398B1 (en) 2004-08-24
EP1200066A1 (de) 2002-05-02
ES2199845T3 (es) 2004-03-01
EP1200066B1 (de) 2003-05-21

Similar Documents

Publication Publication Date Title
DE60002885D1 (de) Wässrige formulierung zur nasalen verabreichung
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
ES2164767T3 (es) Formulaciones de propionato de fluticasona.
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
SE9704186D0 (sv) New composition of matter
CY2014005I2 (el) Τοπικα συστηματα παροχης γελης για την θεραπευτικη αντιμετωπιση των διαταραχων δερματος
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
EP0923376A4 (de) Behandlung von asthma und atemwegerkrankungen
WO2005041921A3 (en) Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
IL179012A0 (en) Method and composition for treating rhinitis
ATE326947T1 (de) Thixotropes nasenspray
EE200300513A (et) Piperasinoderivaadid, nende kasutamine hingamisteede haigusnähte leevendavate ravimite valmistamiseks ning neid sisaldavad ravimid
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
ATE353231T1 (de) Pharmazeutische zusammensetzungen
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
WO2001028535A3 (en) Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate
UA83018C2 (uk) Комбінація рофлуміласту і формотеролу для лікування захворювань дихальних шляхів
WO2003030862A3 (en) Anaesthetic compositions and method for their administration
SE0103210D0 (sv) New formulations and use thereof
CO5690571A2 (es) Combinacion sinergica que comprende roflumilas y (r,r)-formoterol
ATE340576T1 (de) Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties